Instructions for Instructions for Immunomax (Peptidoglycan acidic from potato sprouts) 200 ED lyophilisate for injection
English product name Immunomax
Immunomaxe
Release form
lyophilizate d/r-fit d/v/m is introduced. 100 UNITS: amp.
Description
Lyophilizate for preparation of solution for injection in/m in the form of white powder.
1 fl
acid peptidoglycan with a molecular mass of 1000-40 000 kD 200 UNITS
Solvent: water d/i - 2 ml.
200 IU - bottles (1) with solvent (amp.), syringes and pre-exposure wipes - cardboard packs.
200 IU - bottles (3) with solvent (amp.), syringes and pre-exposure wipes - cardboard packs.
ATC codes
L03AX Other immunostimulators
Clinical-pharmacological groups / Group affiliation
Immunostimulating preparation
Active substance
acid peptidoglycan with a molecular mass of 1000-40 000 kD
Pharmacotherapy group Immunomax:
Immunostimulating agent
Storage Conditions
The drug should be stored at a temperature of 4° to 8°C.
Best before date Immunomax
The shelf life is two years.
Conditions of leave from pharmacies
The drug is prescription.
Testimony Immunomax:
- correction of weakened immunity;
- treatment of pathological conditions (condylomas,
- warts, dysplasia) caused by human papillomavirus;
- infections caused by Herpes simplex,
- Chlamydia spp.,
- Mycoplasma spp.,
- Ureaplasma spp., other bacteria and viruses.
Method of use, course and dosage:
The recommended dose for adults and children aged 12 years and older is 100-200 IU/m 1 times/day.
Prior to consumption, the contents of the vial (ampoules) are dissolved in 1 ml of water, and 100-200 IU is added per m, depending on the severity of the disease. Treatment course - 6 injections in 1, 2, 3, 8, 9, 10 days of treatment.
For recurrent anogenital warts, a course of 6 injections of 200 IU of Immunomax is combined with destruction of warts (cryodestruction, electrocoagulation, laser destruction or application of the drug solcoderm).
For infections caused by bacteria or viruses, a course of 6 injections of 100-200 Immunomax units is carried out.
A course of 3-6 injections of 100-200 IU of Immunomax is carried out to correct weakened immunity.
Contraindications for use
Children under 12 years of age;
increased sensitivity to the drug.
Special Instructions
The preparation can be used as part of complex therapy according to indications.
Use in children Immunomax
The drug is contraindicated in children under 12 years of age.
- Nosology (ICD codes)
- A56.0
- Chlamydia infections of the lower urinary tract
- A56.1
- Chlamydia infections of pelvic organs and other urinary organs
- A60
- Anogenital herpes virus infection [herpes simplex]
- A63.0
- Anogenital [venereal] warts (pointed confectioners)
- B00
- Infections caused by herpes simplex virus [herpes simplex]
- B07
- Viral warts
- B97.7
- Papillomaviruses as a cause of diseases classified in other headings
- D89
- Other immune system disorders not classified in other categories
- N87
- Cervical dysplasia
Pharmacological effect Immunomax:
Immunomodulator. Enhances immune defense against viral and bacterial infections. Immunopharmacological mechanisms of action of the drug consist in that Immunomax activates the following links of the immune system:
NK cells that, two to three hours after Immunomax is administered, strongly express CD69 activation molecules. Cytolithic activity of NK cells increases three-fold;
circulating monocytes begin secreting cytokines two to four hours after Immunomax activation: interleukin-8, interleukin-1β and tumor necrosis factor alpha;